These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12690293)

  • 1. Pharmacological action of high doses of melatonin on B16 murine melanoma cells depends on cell number at time of exposure.
    Yerneni LK; Jayaraman S
    Melanoma Res; 2003 Apr; 13(2):113-7. PubMed ID: 12690293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin interactions with cultured murine B16 melanoma cells.
    Helton RA; Harrison WA; Kelley K; Kane MA
    Melanoma Res; 1993 Dec; 3(6):403-13. PubMed ID: 8161880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of melatonin on melanoma cells subjected to UVA and UVB radiation in In vitro studies.
    Izykowska I; Gebarowska E; Cegielski M; Podhorska-Okolow M; Piotrowska A; Zabel M; Dziegiel P
    In Vivo; 2009; 23(5):733-8. PubMed ID: 19779108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-protective activity of selenomethionine and D-panthetine in B16 melanoma-bearing mice under doxorubicin treatment is not connected with their ROS scavenging potential.
    Panchuk RR; Skorokhyd NR; Kozak YS; Lehka LV; Moiseenok AG; Stoika RS
    Croat Med J; 2017 Apr; 58(2):171-184. PubMed ID: 28409500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct antiproliferative effects of melatonin on two metastatic cell sublines of mouse melanoma (B16BL6 and PG19).
    Cos S; Garcia-Bolado A; Sánchez-Barceló EJ
    Melanoma Res; 2001 Apr; 11(2):197-201. PubMed ID: 11333131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines.
    Fischer TW; Zmijewski MA; Zbytek B; Sweatman TW; Slominski RM; Wortsman J; Slominski A
    Int J Oncol; 2006 Sep; 29(3):665-72. PubMed ID: 16865283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
    Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on inhibitory effect of ampelopsin on melanoma by serologic pharmacological method].
    Liu D; Luo M
    Zhong Yao Cai; 2001 May; 24(5):348-50. PubMed ID: 12587211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice.
    Otálora BB; Madrid JA; Alvarez N; Vicente V; Rol MA
    J Pineal Res; 2008 Apr; 44(3):307-15. PubMed ID: 18339126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin as a Repurposed Drug for Melanoma Treatment.
    Pathipaka R; Thyagarajan A; Sahu RP
    Med Sci (Basel); 2023 Jan; 11(1):. PubMed ID: 36649046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatic action of melatonin: facts and question marks.
    Pawlikowski M; Winczyk K; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic activity of coumarin metabolites and derivatives in the B16-F10 murine melanoma cell line.
    Jiménez-Orozco FA; Molina-Guarneros JA; Mendoza-Patiño N; León-Cedeño F; Flores-Pérez B; Santos-Santos E; Mandoki JJ
    Melanoma Res; 1999 Jun; 9(3):243-7. PubMed ID: 10465579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The validity of melatonin as an oncostatic agent.
    Panzer A; Viljoen M
    J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat.
    Cini G; Coronnello M; Mini E; Neri B
    Cancer Lett; 1998 Mar; 125(1-2):51-9. PubMed ID: 9566696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of biorhythm regulator melatonin on DNA synthesis in short-term cultures of human malignant tumors].
    Riabykh TP; Nikolaeva TG; Bodrova NB
    Vestn Ross Akad Med Nauk; 2000; (8):30-3. PubMed ID: 11022419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells.
    Winczyk K; Lawnicka H; Pawlikowski M; Kunert-Radek J; Karasek M
    Neuro Endocrinol Lett; 2006 Jun; 27(3):351-4. PubMed ID: 16816834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MT-1 melatonin receptor expression increases the antiproliferative effect of melatonin on S-91 murine melanoma cells.
    Kadekaro AL; Andrade LN; Floeter-Winter LM; Rollag MD; Virador V; Vieira W; Castrucci AM
    J Pineal Res; 2004 Apr; 36(3):204-11. PubMed ID: 15009512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of murine melanoma with bryostatin 1.
    Schuchter LM; Esa AH; May S; Laulis MK; Pettit GR; Hess AD
    Cancer Res; 1991 Jan; 51(2):682-7. PubMed ID: 1985785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.